Emerging Incretin-Based Therapies for Type 2 Diabetes: Incretin Mimetics and DPP-4 Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-6417|4|2|101-109

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.4, Iss.2, 2008-05, pp. : 101-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incretin-based Therapies for Type 2 Diabetes Mellitus: Effects on Insulin Resistance

By  

Current Diabetes Reviews, Vol. 9, Iss. 5, 2013-09 ,pp. : 412-417

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac Protection via Metabolic Modulation: An Emerging Role for Incretin-Based Therapies?

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 10, Iss. 4, 2012-01 ,pp. : 319-324

Bentham Science Publishers

Access to resources Recommend Favorite

Incretin Pharmacology: A Review of the Incretin Effect and Current Incretin-Based Therapies

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 10, Iss. 4, 2012-12 ,pp. : 276-288

Bentham Science Publishers

Access to resources Recommend Favorite

An Update in Incretin-Based Therapy: A Focus on Dipeptidyl Peptidase - 4 Inhibitors

By  

Current Diabetes Reviews, Vol. 8, Iss. 3, 2012-05 ,pp. : 169-182

Bentham Science Publishers

Access to resources Recommend Favorite

Incretin for the continuing treatment of secondary failure to metformin in Type 2 diabetes

By Gallwitz Baptist  

Diabetes Management, Vol. 3, Iss. 4, 2013-07 ,pp. : 323-331

Future Medicine

Access to resources Recommend Favorite